Less Ads, More Data, More Tools Register for FREE

Pin to quick picksUkrproduct Regulatory News (UKR)

Share Price Information for Ukrproduct (UKR)

Share Price is delayed by 15 minutes
Get Live Data
6.975    0.00 (0.00%)
Bid:
6.00
Ask:
7.95
Spread: 1.95 (32.50%)
Market Cap: £2.77m
UKR Live PriceLast checked at - London Stock Exchange

Intraday Ukrproduct Share Chart

TRADING UPDATE

15 Jan 2016 11:30

RNS Number : 0353M
Ukrproduct Group Ltd
15 January 2016
 

 

 

FOR IMMEDIATE RELEASE January 15, 2016

 

TRADING UPDATE

 

Kyiv, Ukraine - 15 January 2016 - Ukrproduct Group Limited ("Ukrproduct" or the "Group") (AIM: UKR), one of the leading Ukrainian producers and distributors of branded dairy foods and beverages (kvass), today announces a trading update as the 2015 trading period drew to a close. The full year financial results are expected to be released in the second quarter of 2016.

Over the year Ukrproduct faced significant headwinds. The Ukrainian economy continued under pressure accentuated by the unrest in the East of the country. This has reflected in the major devaluation of its currency, deterioration of consumer confidence and geographic contraction of the available market. Closure of the Russian market further intensified the local competition.

Trading - Whilst revenues in hryvnia terms grew, the overall gross profit in dairy products suffered a significant downturn. This was caused by the rising prices of raw materials including the raw milk and imported components. The compensating pricing was difficult and reduced demand further. In addition, volumes contracted as the Company has sought to manage its counterparty risk by stopping selling to customers with weak credit ratings.

Revenue growth in hryvnia terms resulted from increased sales of packaged butter, hard cheese and third party orders, in particular a 25% increase in skimmed milk powder sales. Other product lines such as processed cheese, processed cheese product and bulk and packaged spreads were marginally down on the previous period. Sales and profitability of the beverage, Kvass, grew marginally, this was achieved by adjusting the sales mix. Kvass production is becoming increasingly important for the company business going forward.

The export business has been increasingly successful and given the devaluation is pursued further. To this end recently the access to China and Kazakhstan markets has been approved and opportunities there are being sought.

Finances

The overall financial performance was undermined by the fall in gross profit given the cost increase and the decline in volumes. The ongoing efficiency improvement program has been able to offset these factors to some extent although EBITDA still fell significantly. This decline was accentuated by the devaluation of hryvnia, weakening approximately 52% against the pound versus the comparative financial period, which induced increase in the interest rates and produced the negative exchange difference leading to an overall loss in 2015. However, the cash flow situation has been significantly improved by the careful working capital management including debtors.

As the cost of the EBRD euro denominated loan was inflated by the devaluation of hryvnya, the bank undertook a thorough business review as a part of the loan restructuring negotiations. That resulted in the agreement with EBRD to restructured terms including the extension of the maturity date of the loan from 2018 to 2024 and a year's grace period. The Board believes that these terms provide confidence and are favourable for the Group relieving immediate pressure on cash flow whilst ensuring that the loan will be repaid in full over a longer period. The Group expects to finalise documentation on restructuring of the loan with EBRD during the first half of 2016.

Outlook

Ukrproduct's business is being reset to operate successfully in a very challenging market place. To that end a comprehensive review programme of the business operations and practices is underway. Given the volatile environment the working capital and capital expenditure are subject to day-to-day monitoring and stringent control. The sales and marketing departments are focused on further penetration of the Ukrainian market (excluding occupied Crimea and the eastern territories). The kvass business remains one of the major focus areas of further growth. Additionally, the Group undertakes further expansion of its export sales seeing high potential in the markets of EU, China and Kazakhstan. Moreover, the manufacturing facilities are being streamlined and further utilised for third party products. Finally, overheads are being materially reduced. Undoubtedly, there is more to do to ensure that Ukrproduct's business adapts to and is synchronised with current market conditions but we are pursuing a structured plan to return to profitability.

 

***

For further information, please visit www.ukrproduct.com or contact: 

Ukrproduct Group Ltd

Jack Rowell, Non-Executive Chairman

Tel: +380 44 232 9602 

Sergey Evlanchik, Chief Executive Officer

 

www.ukrproduct.com

ZAI Corporate Finance Ltd.

Nominated Adviser and Broker

Richard Morrison, Irina Lomova

Tel: +44 20 7060 2220

www.zaicf.com

Ukrproduct Group Ltd is one of the leading Ukrainian producers and distributors of branded dairy products and kvass, a traditional fermented beverage. The Group's product portfolio includes processed and hard cheese, packaged butter, skimmed milk powder (SMP) and kvass. Ukrproduct has built a range of recognisable product brands ("Our Dairyman", "People's Product", "Creamy Valley", "Molendam", "Farmer's") that are well known and highly regarded by consumers. The Group reported total assets of approximately GBP 13.5 million as at June 30, 2015 and consolidated revenues of approximately GBP 9.8 million for the six months ended June 30, 2015. Ukrproduct's securities are traded under the symbol "UKR" on AIM, a market operated by the London Stock Exchange.

Some of the information in this press release may contain projections or other forward-looking statements regarding future events or the future financial performance of the Group. You can identify forward looking statements by terms such as "expect," "believe," "anticipate," "estimate," "intend," "will," "could," "may" or "might" the negative of such terms or other similar expressions. These statements are only predictions and they may differ materially from the actual events or results. We do not intend to update these statements to reflect events and circumstances occurring after the date hereof or to reflect the occurrence of unanticipated events. Many factors could cause the actual results to differ materially from those contained in such projections or forward-looking statements, including, among others, general economic conditions, our competitive environment, risks associated with operating in Ukraine, rapid technological and market change in our industry, as well as many other risks specifically related to the Group and its operations.

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
STRLLFFLLVIELIR
Date   Source Headline
28th May 202612:39 pmRNSOperational Update
18th Dec 20257:00 amRNSTrading Update
1st Oct 20257:00 amRNSAppointment of Director
30th Sep 20257:00 amRNSInterim Results
7th Aug 20255:52 pmRNSResult of Annual General Meeting
17th Jul 20257:00 amRNSDirector’s Purchase of Shares
30th May 20259:00 amRNSFinal Results and Notice of AGM
4th Apr 20257:00 amRNS-RAppointment – Chief Financial Officer
14th Feb 20257:00 amRNSEBRD notification of loan deferral fee accrual
30th Sep 20242:02 pmRNSInterim Results
2nd Sep 20247:00 amRNSAppointment of Non-Executive Chairman
1st Aug 20243:55 pmRNSResult of Annual General Meeting
25th Jun 20247:00 amRNSFinal Results and Notice of AGM
20th Jun 20249:03 amRNSBoard Changes
28th Sep 202312:00 pmRNSInterim Results June 2023
3rd Aug 20234:50 pmRNSResult of AGM
29th Jun 20231:30 pmRNSFinal Results and Notice of AGM
16th Mar 20234:41 pmRNSSecond Price Monitoring Extn
16th Mar 20234:35 pmRNSPrice Monitoring Extension
4th Nov 20227:00 amRNSResult of AGM
30th Sep 20227:00 amRNSUnaudited Interim Results
29th Sep 20227:30 amRNSRestoration - Ukrproduct Group Ltd
29th Sep 20227:00 amRNSFinal Results and Notice of AGM
31st Aug 20227:00 amRNSUpdate on Publication of 2021 Accounts
1st Jul 20227:30 amRNSSuspension - Ukrproduct Group Ltd
1st Jul 20227:00 amRNSTrading Update 2021
7th Jun 202211:30 amRNSUpdate on Publication of 2021 Accounts
1st Mar 202212:00 pmRNSUpdate due to Russian Invasion
27th Sep 20217:00 amRNSInterim Results
23rd Jul 20219:20 amRNSResult of AGM
25th Jun 20217:32 amRNSFinal Results and Notice of AGM
18th May 202110:00 amRNSTrading Update for 2020
30th Sep 20207:00 amRNSInterim Results
30th Jul 20205:15 pmRNSResult of AGM
29th Jun 20208:20 amRNSFinal Results and Notice of AGM
19th Mar 20207:00 amRNSYear End Trading Update
2nd Sep 20197:00 amRNSInterim Results
31st Jul 20198:42 amRNSResult of AGM
27th Jun 20197:00 amRNSFinal Results
7th May 20197:00 amRNSYear End Trading Update
26th Sep 20185:15 pmRNSHalf-year Report
3rd Aug 20185:30 pmRNSResult of AGM
27th Jun 20185:00 pmRNSFinal Results
3rd Apr 20187:00 amRNSYear End Trading Update
9th Feb 20187:00 amRNSRepayment of OTP Bank Loan
7th Feb 20187:00 amRNSNew Loan Agreement
11th Dec 20177:00 amRNSUpdate regarding the OTP Bank Loan
20th Nov 20177:30 amRNSRestoration - Ukrproduct Group Limited
20th Nov 20177:00 amRNSNomad Appointment & Resumption of Trading
19th Oct 20177:00 amRNSSuspension - Ukrproduct Group Ltd

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.